These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21883330)

  • 1. Population pharmacokinetics of fluconazole after administration of fosfluconazole and fluconazole in critically ill patients.
    Aoyama T; Hirata K; Hirata R; Yamazaki H; Yamamoto Y; Hayashi H; Matsumoto Y
    J Clin Pharm Ther; 2012 Jun; 37(3):356-63. PubMed ID: 21883330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of renal impairment on the pharmacokinetics and safety of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
    Sobue S; Tan K; Layton G; Leclerc V; Weil A
    Br J Clin Pharmacol; 2004 Jun; 57(6):773-84. PubMed ID: 15151523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and safety of Fosfluconazole after single intravenous bolus injection in healthy male Japanese volunteers.
    Sobue S; Sekiguchi K; Shimatani K; Tan K
    J Clin Pharmacol; 2004 Mar; 44(3):284-92. PubMed ID: 14973307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole.
    Sobue S; Tan K; Haug-Pihale G
    Br J Clin Pharmacol; 2005 Feb; 59(2):160-6. PubMed ID: 15676037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fluconazole in people with HIV infection: a population analysis.
    McLachlan AJ; Tett SE
    Br J Clin Pharmacol; 1996 Apr; 41(4):291-8. PubMed ID: 8730974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole Population Pharmacokinetics after Fosfluconazole Administration and Dosing Optimization in Extremely Low-Birth-Weight Infants.
    Tanzawa A; Saito J; Shoji K; Kojo Y; Funaki T; Maruyama H; Isayama T; Ito Y; Nakamura H; Yamatani A
    Microbiol Spectr; 2022 Apr; 10(2):e0195221. PubMed ID: 35266811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics of fosfluconazole and fluconazole after single intravenous administration of fosfluconazole in healthy Japanese and Caucasian volunteers.
    Sobue S; Tan K; Shaw L; Layton G; Hust R
    Eur J Clin Pharmacol; 2004 Jun; 60(4):247-53. PubMed ID: 15103438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nonclinical studies and clinical studies on fosfluconazole, a triazole antifungal agent (Prodif)].
    Kawakami Y; Nagino K; Shinkai K; Sobue S; Abe M; Ishiko J
    Nihon Yakurigaku Zasshi; 2004 Jul; 124(1):41-51. PubMed ID: 15226621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.
    Debruyne D
    Clin Pharmacokinet; 1997 Jul; 33(1):52-77. PubMed ID: 9250423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteral fluconazole population pharmacokinetics in patients in the surgical intensive care unit.
    Rajagopalan P; Pelz RK; Lipsett PA; Swoboda SM; Rinaldi MG; Hendrix CW
    Pharmacotherapy; 2003 May; 23(5):592-602. PubMed ID: 12741433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of fluconazole in loggerhead sea turtles (Caretta caretta) after single intravenous and subcutaneous injections, and multiple subcutaneous injections.
    Mallo KM; Harms CA; Lewbart GA; Papich MG
    J Zoo Wildl Med; 2002 Mar; 33(1):29-35. PubMed ID: 12216790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of fluconazole in young infants.
    Wade KC; Wu D; Kaufman DA; Ward RM; Benjamin DK; Sullivan JE; Ramey N; Jayaraman B; Hoppu K; Adamson PC; Gastonguay MR; Barrett JS;
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4043-9. PubMed ID: 18809946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
    Patel K; Roberts JA; Lipman J; Tett SE; Deldot ME; Kirkpatrick CM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function.
    Buijk SL; Gyssens IC; Mouton JW; Verbrugh HA; Touw DJ; Bruining HA
    Intensive Care Med; 2001 Jan; 27(1):115-21. PubMed ID: 11280621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole serum concentrations and pharmacokinetics in an obese patient.
    Cohen LG; DiBiasio A; Lisco SJ; Hurford WE
    Pharmacotherapy; 1997; 17(5):1023-6. PubMed ID: 9324192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus.
    Bafeltowska JJ; Buszman E
    Chemotherapy; 2005 Oct; 51(6):370-6. PubMed ID: 16227694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of fluconazole in patients after cytotoxic chemotherapy for hematological malignancy.
    Kami M; Sawada Y; Mori S; Hirate J; Kojima N; Kanda Y; Moriya A; Yuji K; Saito T; Chiba S; Hirai H
    Am J Hematol; 2001 Feb; 66(2):85-91. PubMed ID: 11421304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D; Noppakun K; Rojanasthien N; Kanchanarattanakorn K; Jittikanont S; Manoyot A; Bunnachak D; Ophascharoensuk V
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
    Gharibian KN; Mueller BA
    Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.